Molecular Testing May Be Underused, Delaying Therapy in Metastatic NSCLC
Molecular testing may be underused in patients with metastatic NSCLC and may delay the start of systemic therapy, a study suggests.
Lung Cancers News
LUNG CANCER ADVISOR
Lung Cancers News
Adding Ipilimumab to Standard Care Improves Responses in Operable NSCLC
Adding ipilimumab to nivolumab and chemotherapy improves responses in patients with operable non-small cell lung cancer, a phase 2 trial suggests.
Pentagon Study Finds Higher Cancer Rates Among Pilots, Ground Crews
Military pilots and the ground crews who fuel and maintain their aircraft have higher rates of certain cancers, a new study shows.
Hormone Therapy Linked to Lower Risk of Lung Cancer in Postmenopausal Women
Patients receiving higher doses of hormone therapy and those receiving hormone therapy for at least 5 years may have a lower risk of lung cancer.
Discrimination Tied to Frailty in African-American Cancer Survivors
Among African-American cancer survivors, experiencing discrimination is associated with frailty, a study suggests.
Immunotherapy May Increase the Risk of Treatment Discontinuation in SCLC
Adding immunotherapy to chemotherapy may increase the risk of toxicity and likelihood of treatment discontinuation in patients with SCLC, a meta-analysis suggests.
Upfront Atezolizumab Poses Lower Risk of Hyperprogression in NSCLC
The risk of hyperprogression is lower when atezolizumab is given upfront to patients with advanced non-small cell lung cancer, a study suggests.
Osimertinib and Platinum Chemo Produces Unprecedented Results in NSCLC
A phase 2 trial suggests that frontline osimertinib and platinum-based chemotherapy is safe and effective in EGFR-mutated, advanced NSCLC.
Certain Antibiotics May Reduce the Efficacy of Certain ICIs in Cancer Patients
A new study suggests that fluoroquinolones — but not other antibiotics — may reduce the efficacy of certain ICIs in certain cancers.
COVID-19 Sequelae in Cancer by Vaccination Status and Variant Era
COVID-19 vaccination may reduce the risk of COVID-19 sequelae in patients with cancer, according to researchers.
Artificial Intelligence Can Predict Cancer Survival Using Data From a Single Consultation
Artificial intelligence can predict survival in cancer patients using information from a patient’s initial consultation with an oncologist, a study suggests.
Novel Treatment Approach May Reduce Risk of Death From ICI-Related Myocarditis
A novel method of treating immune checkpoint inhibitor-associated myocarditis may decrease the risk of death from myotoxicity.
Cancer Patients in Nursing Homes More Likely to Receive Aggressive End-of-Life Care
Cancer patients living in nursing homes are more likely to receive aggressive end-of-life care and die in the hospital, a study suggests.
Pembrolizumab Improves 5-Year PFS, OS in Metastatic NSCLC
Five-year data support the use of pembrolizumab plus pemetrexed-platinum chemotherapy as standard care for previously untreated, metastatic, EGFR/ALK-wild-type NSCLC, according to researchers.
Cancer Patients Reported Symptoms of PTSD During First Year of COVID-19 Pandemic
Patients with cancer experienced symptoms of PTSD during the first year of the COVID-19 pandemic, a French study suggests.
Cancer Patients May Be Treated With Drugs That Provide No Benefit
Many cancer patients may be treated with drugs that were granted accelerated approval but do not provide a clinical benefit, a study suggests.
SBRT Well Tolerated, Effective for Primary Lung Neuroendocrine Tumor
SBRT should be offered as an alternative to surgical resection for patients with early-stage LNET, according to researchers.
Delirium Tied to Increased Risk of Death in Critically Ill With Cancer
Critically ill patients with cancer who develop delirium have a higher risk of dying in the hospital or intensive care unit, a study suggests.
Sexual Health and Cancer: What Providers Need to Know
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
Global Incidence of Mesothelioma on the Decline
The global incidence of mesothelioma has decreased in recent years, especially in highly developed countries, researchers found.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Lung Cancer News
Loading... 
Loading...